| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |